|
1
|
Sui W, Morrow DC, Bermejo CE and
Hellenthal NJ: Trends in testicular cancer survival: A large
population-based analysis. Urology. 85:1394–1398. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Richiardi L, Ekbom A, Pukkala E,
Cuninkova M and Møller H: Trends in testicular cancer incidence and
mortality in 22 European countries: Continuing increases in
incidence and declines in mortality. Int J Cancer. 118:3099–3111.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
La Vecchia C, Bosetti C, Lucchini F,
Bertuccio P, Negri E, Boyle P and Levi F: Cancer mortality in
Europe, 2000–2004 and an overview of trends since 1995. Ann Oncol.
21:1323–1360. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Trama A, Mallone S, Nicolai N, Necchi A,
Schaapveld M, Gietema J, Znaor A, Ardanaz E and Berrino F: RARECARE
Working Group: Burden of testicular, paratesticular and
extragonadal germ cell tumours in Europe. Eur J Cancer. 48:159–169.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sender L and Zabokrtsky KB: Adolescent and
young adult patients with cancer: A milieu of unique features. Nat
Rev Clin Oncol. 12:465–480. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Petersen PM, Skakkebaek NE and Giwercman
A: Gonadal function in men with testicular cancer: Biological and
clinical aspects. APMIS. 106:24–34. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tomlinson M, Meadows J, Kohut T, Haoula Z,
Naeem A, Pooley K and Deb S: Review and follow-up of patients using
a regional sperm cryopreservation service: Ensuring that resources
are targeted to those patients most in need. Andrology. 3:709–716.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ng AK, Kenney LB, Gilbert ES and Travis
LB: Secondary malignancies across the age spectrum. Semin Radiat
Oncol. 20:67–78. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Howard R, Gilbert E, Lynch CF, Hall P,
Storm H, Holowaty E, Pukkala E, Langmark F, Kaijser M, Andersson M,
et al: Risk of leukemia among survivors of testicular cancer: A
population-based study of 42,722 patients. Ann Epidemiol.
18:416–421. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Travis LB, Beard C, Allan JM, Dahl AA,
Feldman DR, Oldenburg J, Daugaard G, Kelly JL, Dolan ME, Hannigan
R, et al: Testicular cancer survivorship: Research strategies and
recommendations. J Natl Cancer Inst. 102:1114–1130. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lackner JE, Märk I, Schatzl G, Marberger M
and Kratzik C: Hypogonadism and androgen deficiency symptoms in
testicular cancer survivors. Urology. 69:754–758. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huddart RA, Norman A, Shahidi M, Horwich
A, Coward D, Nicholls J and Dearnaley DP: Cardiovascular disease as
a long-term complication of treatment for testicular cancer. J Clin
Oncol. 21:1513–1523. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Malec JF, Romsaas EP, Messing EM, Cummings
KC and Trump DL: Psychological and mood disturbance associated with
the diagnosis and treatment of testis cancer and other
malignancies. J Clin Psychol. 46:551–557. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fleer J, Hoekstra HJ, Sleijfer DT and
Hoekstra-Weebers JE: Quality of life of survivors of testicular
germ cell cancer: A review of the literature. Support Care Cancer.
12:476–486. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huddart RA and Kataja VV: ESMO Guidelines
Task Force: ESMO minimum clinical recommendations for diagnosis,
treatment and follow-up of testicular seminoma. Ann Oncol. 16(Suppl
1): i40–i42. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huddart RA and Purkalne G: ESMO Guidelines
Task Force: ESMO minimum clinical recommendations for diagnosis,
treatment and follow-up of mixed or non-seminomatous germ cell
tumors (NSGCT). Ann Oncol. 16(Suppl 1): i37–i39. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
International germ cell consensus
classification: A prognostic factor based staging system for
metastatic germ-cell cancers. International Germ Cell Cancer
Collaborative Group. J Clin Oncol. 15:594–603. 1997.PubMed/NCBI
|
|
18
|
Dieckmann KP and Pilchlmeier U: Clinical
epidemiology of testicular germ cell tumors. World J Urol. 22:2–14.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Greene MH, Kratz CP, Mai PL, Mueller C,
Peters JA, Bratslavsky G, Ling A, Choyke PM, Premkumar A, Bracci J,
et al: Familial testicular germ cell tumors in adults: 2010 summary
of genetic risk factors and clinical phenotype. Endocr Relat
Cancer. 17:R109–R121. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Srivastava A and Kreiger N: Cigarette
smoking and testicular cancer. Cancer Epidemiol Biomarkers Prev.
13:49–54. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shinn EH, Swartz RJ, Thornton BB, Spiess
PE, Pisters LL and Basen-Engquist KM: Testis cancer survivors'
health behaviors: Comparison with age-matched relative and
demographically matched population controls. J Clin Oncol.
28:2274–2279. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Abern MR, Dude AM and Coogan CL: Marital
status independently predicts testis cancer survival-an analysis of
the SEER database. Urol Oncol. 30:487–493. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bokemever C, kuczyk MA, Köhne H, Einsele
H, Kynast B and Schmoll HJ: Hematopoietic growth factors and
treatment of testicular cancer: Biological interactions, routine
use and dose-intensive chemotherapy. Ann Hematol. 72:1–9. 1996.
View Article : Google Scholar
|
|
24
|
Damjanov I and Wewer-Albrechtsen N:
Testicular germ cell tumors and related research from a historical
point of view. Int J Dev Biol. 57:197–200. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: GLOBOCAN 2008 v1.2, Cancer Incidence and
Mortality Worldwide: IARC CancerBase No. 10 (Internet).
International Agency for Research on Cancer (Lyon, France).
2010.http://globocan.iarc.frAccessed. December
12–2014PubMed/NCBI
|
|
26
|
Shanmugalingam T, Soultati A, Chowdhury S,
Rudman S and Van Hemelrijck M: Global incidence and outcome of
testicular cancer. Clin Epidemiol. 5:417–427. 2013.PubMed/NCBI
|
|
27
|
Reilley MJ, Jacobs LA, Vaughn DJ and
Palmer SC: Health behaviors among testicular cancer survivors. J
Community Support Oncol. 12:121–128. 2014.PubMed/NCBI
|
|
28
|
Fosså SD, Dahl AA and Loge JH: Fatigue,
anxiety and depression in long-term survivors of testicular cancer.
J Clin Oncol. 21:1249–1254. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hotaling JM, Patel DP, Vendryes C,
Lopushnyan NA, Presson AP, Zhang C, Muller CH and Walsh TJ:
Predictors of sperm recovery after cryopreservation in testicular
cancer. Asian J Androl. 18:35–38. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Magelssen H, Brydøy M and Fosså SD: The
effects of cancer and cancer treatments on male reproductive
function. Nat Clin Pract Urol. 3:312–322. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Brydøy M, Fosså SD, Klepp O, Bremnes RM,
Wist EA, Wentzel-Larsen T and Dahl O: Paternity following treatment
for testicular cancer. Nat Cancer Inst. 97:1580–1588. 2005.
View Article : Google Scholar
|
|
32
|
Richiardi L, Scélo G, Boffetta P, Hemminki
K, Pukkala E, Olsen JH, Weiderpass E, Tracey E, Brewster DH,
McBride ML, et al: Second malignancies among survivors of germ-cell
testicular cancer: A pooled analysis between 13 cancer registries.
Int J Cancer. 120:623–631. 2007. View Article : Google Scholar : PubMed/NCBI
|
